EVFM 2018 Proxy Statement

35 New Plan Benefits The following table shows the total number of awards expected to be made under the increase to the Amended and Restated 2014 Plan to the identified individuals and groups, which awards are subject to the approval of the Amended and Restated 2014 Plan by our stockholders: Name and Position Number of Shares Saundra Pelletier, President and Chief Executive Officer 825,000 Justin J. File, Chief Financial Officer 300,000 Alexander A. Fitzpatrick, Secretary and General Counsel 275,000 Kelly Culwell, M.D., Chief Medical Officer 260,000 Russ Barrans, Chief Commercial Officer 260,000 *Thomas Lynch, Chairman and Director 225,000 Thomas Lynch, Chairman and Director 24,691 Colin Rutherford, Director 39,691 Gillian Greer, Ph.D., Director 24,691 William Hall, Ph.D, M.D., Director 24,691 Tony O’Brien, Director 24,691 Non-executive employees and consultants 852,575 Total 3,136,030 * Option granted in connection with consulting services provided to Evofem Biosciences Operations, Inc. Except as set forth in the table above or pursuant to our Amended and Restated Non-Employee Director Compensation Policy, the amounts of future grants under the Amended and Restated 2014 Plan are not determinable as awards under the Amended and Restated 2014 Plan and will be granted at the sole discretion of the Compensation Committee, the Board or other delegated persons, and we cannot determine at this time either the persons who will receive awards, which may include the persons listed in the table above, under the Amended and Restated 2014 Plan or the amount or types of any such awards. Recommendation THE BOARD OF DIRECTORS RECOMMENDS APPROVAL OF THE AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN WHICH INCLUDES AN INCREASE IN THE NUMBER OF AUTHORIZED SHARES UNDER THE 2014 PLAN FROM 458,586 SHARES TO 5,300,000 SHARES OF COMMON STOCK AVAILABLE FOR THE GRANT OF AWARDS, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR OF THE AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN UNLESS A STOCKHOLDER HAS INDICATED OTHERWISE ON THE PROXY.